Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU accession countries sign up to electronic aid:

This article was originally published in Clinica

Executive Summary

Six EU accession countries have joined the pan-European electronic infrastructure that the EU institutions and member states use to exchange data for applying EU law and enforcing single market rules to help them take up and implement EU legislation. Slovenia, Poland, the Czech Republic, Malta, Estonia and Cyprus have signed a memorandum of understanding with the European Commission, formalising their participation in the project, known as the IDA (Interchange of Data between Administrations) programme. IDA is also used to supply e-government services across borders and is seen as an essential support to the speedy implementation of modern e-government solutions, as foreseen in the "eEurope 2005 Action Plan". Hungary will be the next to sign a memorandum of understanding and the remaining accession countries, Latvia, Lithuania and Slovakia and three candidate countries, Bulgaria, Romania and Turkey, will follow in 2003.

You may also be interested in...

IPO Year In Review: Record-Year Bodes Well For 2021, And For More SPACs

Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.

Abbott Capitalizes On Pandemic Testing Boom; Device Sales Stay Almost Flat

Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.

Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients

While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts